|1.||Leucht, Stefan: 2 articles (02/2015 - 01/2014)|
|2.||Juckel, Georg: 2 articles (03/2014 - 08/2011)|
|3.||Stargardt, Tom: 2 articles (03/2014 - 08/2011)|
|4.||Chanpattana, Worrawat: 2 articles (12/2010 - 09/2003)|
|5.||Landen, H: 2 articles (09/2009 - 07/2004)|
|6.||Philipp, Michael: 2 articles (06/2007 - 05/2003)|
|7.||Schmauss, Max: 2 articles (06/2007 - 05/2003)|
|8.||Glaser, Thomas: 2 articles (05/2003 - 04/2003)|
|9.||Chanpattana, W: 2 articles (12/2001 - 08/2000)|
|10.||Chakrabhand, M L: 2 articles (12/2001 - 08/2000)|
|1.||Schizophrenia (Dementia Praecox)
09/01/1999 - "In patients with treatment-resistant schizophrenia (TRS), this study compared the efficacy of continuation treatment with flupenthixol alone, continuation electroconvulsive therapy (ECT) alone, and combined continuation ECT and flupenthixol. "
01/01/2012 - "All randomised controlled trials (RCTs) that compared flupenthixol with placebo for adults with schizophrenia or related disorders by any means of diagnosis. "
09/01/2009 - "The results of this study suggest that flupentixol is a potent and safe antipsychotic for the long-term treatment of schizophrenia in routine clinical practice."
07/01/2004 - "The objective of this phase IV surveillance study was to document the efficacy and tolerability of flupenthixol as well as the quality of life of patients suffering from schizophrenia and to gain insights into which doses were actually used in specialists outpatients care. "
03/01/2014 - "Flupentixol has a stable place in the treatment of schizophrenia in spite of the introduction of different SGAs. "
|2.||Depressive Disorder (Melancholia)
08/01/1976 - "In an open, uncontrolled trial flupenthixol was administered to 45 patients with endogenous depression. "
11/01/1997 - "There are no data available on the risk of extrapyramidal symptoms when using long-term flupenthixol in low dosage in patients suffering from anxiety and depressive disorders. "
01/01/1986 - "Neurotic depression accompanied by somatic symptoms: a double-blind comparison of flupenthixol and diazepam in general practice."
01/01/1979 - "A double-blind trial of flupenthixol, nortriptyline and diazepam in neurotic depression using flexible dose schedules suggested that each drug is an efficient treatment for this category of depression although the patterns of response and prevalence of side-effects varied. "
01/01/1979 - "A double-blind comparison of flupenthixol, nortriptyline and diazepam in neurotic depression."
|3.||Psychophysiologic Disorders (Psychosomatic Disorders)
09/01/1992 - "1. A number of controlled as well as uncontrolled studies indicate that flupenthixol in a low-dose regimen is effective in treating syndromes with depression, anxiety, and psychosomatic disorders. "
01/01/1984 - "Flupenthixol versus diazepam in the treatment of psychosomatic disorders: a double-blind, multi-centre trial in general practice."
01/01/1985 - "Psychosomatic disorders in general practice: comparisons of treatment with flupenthixol, diazepam and sulpiride."
07/01/1971 - "Flupenthixol (fluanxol) in the treatment of psychosomatic disorders in medicine."
01/01/1984 - "In a Finnish general practice 120 patients with psychosomatic disorders, manifest as syndromes of tension headache, cardiac neurosis, dizziness or muscular tension, were randomly allocated to treatment over a 4-week period with either flupenthixol (1 to 2 mg per day) or diazepam (5 to 10 mg mg per day). "
02/01/1978 - "1 alpha-Flupenthixol (alpha-FPT; 0.2 mg/kg i.p.) when administered to rats produced catalepsy. "
01/01/2009 - "Our study reports strong evidence to show that hypokinesia and catalepsy induced by alpha-flupentixol are triggered by dramatic changes occurring in basal ganglia network. "
07/01/1988 - "Rats receiving cis-flupentixol demonstrated tolerance to its cataleptogenic effects, with a significant reduction in catalepsy observed by treatment day 7. During the 3 week treatment, the time between drug injection and a full cataleptic response to cis-flupentixol increased from 20 to 60 min, suggesting a tolerance to the D2, but not D1, dopamine receptor antagonism by cis-flupentixol.(ABSTRACT TRUNCATED AT 400 WORDS)"
01/01/1990 - "Mixed D-1/D-2 antagonists, haloperidol (HPD) and cis-flupentixol (FLU) also induced catalepsy at doses of 2.0 and 0.8 mg/kg, SC, respectively. "
02/01/1978 - "The effect of baclofen on alpha-flupenthixol-induced catalepsy in the rat."
06/01/2008 - "To study the efficacy of a combination of flupenthixol and melitracen (F + M) with anxiolytic and antidepressant properties in functional dyspepsia using a randomized controlled cross-over design. "
06/01/2008 - "Clinical trial: a randomized controlled cross-over study of flupenthixol + melitracen in functional dyspepsia."
|4.||Risperidone (Risperdal Consta)
|7.||Dopamine Receptors (Dopamine Receptor)
|8.||Antipsychotic Agents (Antipsychotics)
|3.||Transcutaneous Electric Nerve Stimulation (TENS)